Glaukos (GKOS) Debt Ratio (2014 - 2021)
Glaukos (GKOS) posted quarterly Debt Ratio of 0.27 for Q2 2021, down 1.89% quarter-over-quarter from 0.27 in Q1 2021.
Glaukos (GKOS) Debt Ratio (2014 - 2021) Analysis & Trends
Glaukos (GKOS) has reported Debt Ratio for 5 consecutive years, with 0.27 the latest figure, recorded in Q2 2021.
- In Q2 2021, Debt Ratio changed N/A year-over-year to 0.27; the TTM figure through Jun 2021 stood at 0.27 (changed N/A YoY), while the FY2020 annual figure was 0.09, changed N/A from the prior year.
- Debt Ratio fell to 0.27 in Q2 2021 per GKOS's latest filing, from 0.27 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.27 in Q1 2021 and bottomed at 0.09 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 0.18 |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 0.27 |
| Mar 31, 2021 | 0.27 |
| Dec 31, 2020 | 0.09 |
| Sep 30, 2016 | 0.02 |
| Jun 30, 2016 | 0.04 |
| Mar 31, 2016 | 0.06 |
| Dec 31, 2015 | 0.08 |
| Sep 30, 2015 | 0.10 |
| Jun 30, 2015 | 0.16 |
| Dec 31, 2014 | 0.67 |